JP Patent

JP2004535442A — 修飾ｇｌｐ−１の安定な処方剤

Assigned to Novo Nordisk AS · Expires 2004-11-25 · 21y expired

What this patent protects

【課題】【解決手段】ＧＬＰ−１化合物の薬学的処方剤、およびそれらの調製方法。

USPTO Abstract

【課題】【解決手段】ＧＬＰ−１化合物の薬学的処方剤、およびそれらの調製方法。

Drugs covered by this patent

Ozempic (semaglutide) · Novo Nordisk

Patent Metadata

Patent number: JP2004535442A
Jurisdiction: JP
Classification: —
Expires: 2004-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Novo Nordisk AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.